These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8847705)
1. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes. Hong JT; Wilson MW; Glauert HP J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705 [TBL] [Abstract][Full Text] [Related]
2. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745 [TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats. Leung LK; Glauert HP Toxicology; 1997 Nov; 123(1-2):101-9. PubMed ID: 9347925 [TBL] [Abstract][Full Text] [Related]
4. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes. Hong JT; Glauert HP J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198 [TBL] [Abstract][Full Text] [Related]
5. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes. Hong JT; Yun YP Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418 [TBL] [Abstract][Full Text] [Related]
6. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Glauert HP; Beer D; Rao MS; Schwarz M; Xu YD; Goldsworthy TL; Coloma J; Pitot HC Cancer Res; 1986 Sep; 46(9):4601-6. PubMed ID: 2873887 [TBL] [Abstract][Full Text] [Related]
7. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. Leung LK; Glauert HP Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules. Chen ZY; Liu YF; He CY; White CC; Eaton DL Cancer Res; 1994 May; 54(10):2622-9. PubMed ID: 7909493 [TBL] [Abstract][Full Text] [Related]
9. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats. Leung LK; Glauert HP Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093 [TBL] [Abstract][Full Text] [Related]
10. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator. Milano M; Reddy JK; Prasad JD; Rao MS Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433 [TBL] [Abstract][Full Text] [Related]
11. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver. Wilson MW; Leung LK; Hong JT; Glauert HP Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588 [No Abstract] [Full Text] [Related]
12. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Li Y; Leung LK; Glauert HP; Spear BT Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes. Hong JT; Glauert HP Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625 [TBL] [Abstract][Full Text] [Related]
14. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433 [TBL] [Abstract][Full Text] [Related]
15. gamma-Glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acetylaminofluorene administration. Yeldandi AV; Subbarao V; Rajan A; Reddy JK; Rao MS Carcinogenesis; 1989 Apr; 10(4):797-9. PubMed ID: 2564815 [TBL] [Abstract][Full Text] [Related]
16. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ; Winham MA; Old SL; Gray TJ Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300 [TBL] [Abstract][Full Text] [Related]
17. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis. Glauert HP; Clark TD Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376 [TBL] [Abstract][Full Text] [Related]
18. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. Rao MS; Tatematsu M; Subbarao V; Ito N; Reddy JK Cancer Res; 1986 Oct; 46(10):5287-90. PubMed ID: 2875789 [TBL] [Abstract][Full Text] [Related]
19. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. Foxworthy PS; White SL; Hoover DM; Eacho PI Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728 [TBL] [Abstract][Full Text] [Related]
20. Effect of extracellular matrix on the expression of peroxisome proliferation associated genes in cultured rat hepatocytes. Hong JT; Glauert HP Toxicol In Vitro; 2000 Apr; 14(2):177-84. PubMed ID: 10793296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]